← Back to Search

Behavioral Intervention

Supportive Care Models for Cancer

N/A

Recruiting

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must speak English or Spanish

Newly diagnosed patients with a solid tumor cancer diagnosis or hematologic malignancy

Must not have

Plans to change oncologist within 12 months

Inability to consent to the study

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, and 12 months after patient enrollment

Awards & highlights

No Placebo-Only Group

Summary

This trial compares two different approaches to supportive cancer care (SCC), a technology-based approach and a team-based approach.

Who is the study for?

This trial is for English or Spanish-speaking adults newly diagnosed with solid tumor cancers or blood malignancies. They must understand and agree to participate in the study, plan to keep their current oncologist for at least a year, and not be moving from the area soon.

What is being tested?

The study compares two types of supportive care for cancer patients: one uses technology like apps or online tools, while the other relies on a redesigned team approach involving healthcare professionals.

What are the potential side effects?

Since this trial focuses on supportive care rather than direct medical treatments, side effects are not typical as seen with medication trials but may include discomfort from using new technologies or adjusting to team-based care interactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English or Spanish.

Select...

I have been recently diagnosed with cancer.

Select...

I can understand and am willing to consent to participate.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I plan to change my cancer doctor within the next year.

Select...

I am unable to give consent for the study myself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, and 12 months after patient enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, and 12 months after patient enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, and 12 months after patient enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Change in health-related quality of life as assessed by the Functional Assessment of Cancer Therapy (FACT-G).

Change in patient activation using the Patient Activation Measure (PAM-13).

Change in satisfaction with care using the Consumer Assessment of Health Care (Providers and Systems (CAHPS) Cancer Care Survey Questions #39 and #42.

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Redesigned team-based supportive cancer careExperimental Treatment1 Intervention

Patients are paired with a health educator who will discuss the same educational materials from ARM A either in person or by telephone discussions weekly during months 1-4 and every other week during months 5-12.

Group II: Technology-based supportive cancer careActive Control1 Intervention

Patients receive educational materials to assist with advance care planning and symptom management through a technology-based supportive cancer care weekly during months 1-4 and every other week during months 5-12.

0 / 5Eligibility criteria met